All Articles

Finding the right clinical trials should not be an overwhelming endeavor for patients. Explore how navigator training can simplify trial discussions and support patient-centered decision-making.

Smarter, Stronger, Supported: Technology for Every Step of the Cancer Journey

By Hina M. Porcelli

Technology & AI

January 2026 Vol 17, No 1

Technology has the power to ease the burden of oncology navigation without replacing the human connection at its core. In this article we look at emerging tools that are designed to support navigators, streamline workflows, and give them more time for what matters most.

A Look at Navigation With January’s Symbols

By Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN

The Editor’s Take, Web Exclusives

Web Exclusives

January is a time of new beginnings and building resilience by reframing negative habits into more optimistic opportunities. The symbols that represent the month of January are reflective of navigation positive characteristics.

Pirtobrutinib in Covalent BTKi-Treated Patients With CLL/SLL: Translating Clinical Trial Insights Into Real-World Practice

Clinical Trials

Special Issues and Supplements

In their expert commentaries, Jackie Broadway-Duren, PhD, DNP, APRN, FNP-BC, FAANP, and Mollie Moran, APRN-CNP, examine the noncovalent Bruton’s tyrosine kinase (BTK) inhibitor, pirtobrutinib, in the treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

CDK4/6 Inhibitors for Treatment of High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Addressing Tolerability to Maximize Treatment Persistence

We are pleased to announce Part 2 of the new 2-part series, Did You Know? Beyond the Data. Our second article, with video commentary by Hope Rugo, MD, and an accompanying infographic, presents clinical data and real-world evidence on treatment patterns and tolerability considerations for CDK4/6 inhibitors in patients with early breast cancer with high risk of recurrence. We invite you to explore this informative series, designed to empower healthcare professionals with actionable insights to improve patient outcomes.

The Vitality of Oncology Patient Navigation

By Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN

The Editor’s Take

Explore highlights of key progress made in oncology navigation in 2025, including better reimbursement models, improved training, and enhanced support for diverse populations in care and clinical trials.

Honoring Team Excellence in Oncology Patient Navigation

By Hina M. Porcelli

The Director's Cut

Celebrate the power of teamwork in oncology navigation as we honor the winners of the inaugural Dr Harold Freeman One Team Award for their dedication to removing barriers, building trust, and improving patient outcomes through collaboration and innovation.

Transforming Cancer Care Through a Unified Approach

By Erika Trapl, PhD; Sarah Koopman Gonzalez, PhD; Chesley Cheatham, MEd, MCHES; Kristina Austin, MSEd, LSW; Colleen Palay, MPH, BSN, RN; Krista Casazza, PhD, RD, CSSD; Marcie S. Wright, PhD, MPH; Robert A. Winn, MD

Health Equity

Discover the impactful ways that the Case Western Reserve University PARTNERS program is reshaping cancer care through strategic partnerships, communication, and a patient-first approach to equity and access.

Navigation Refresh: Reflections on Your Best Professional Life

By Mandi L. Pratt-Chapman, PhD, MA, HON-OPN-CG

Navigation

In this edition of Navigation Refresh, Mandi L. Pratt-Chapman, PhD, MA, HON-OPN-CG, reflects on how grounding yourself in your principles and prioritizing wellness can empower patient navigators to thrive in their roles and deliver compassionate care.

Using an EPIC-Based Barriers to Care Assessment to Guide Care Navigation in a Large Oncology Service Line

By Sharon Manne; Jeanne Silva, MSN, RN-BC, CN-BN, CMSRN; Dena O'Malley; Shawna Hudson; Ethan A. Halm; Jacintha Peram; Justin D. Solleder; Beth Handorf

Original Research

Dive into a comprehensive look at the implementation of a system-wide navigation program that leverages data to identify barriers, enhance patient education, and support vulnerable populations throughout their cancer journey.

All Articles

Page 2 of 281

Connect with Us

Subscribe Today!

I'd like to receive:

Please enter your mailing address.